Glycosaminoglycan polysulfate in the treatment of old age dementias-Reference-Cited by-同舟云学术

Glycosaminoglycan polysulfate in the treatment of old age dementias

Published:1991-01 Issue:3 Volume:15 Page:323-342
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Ban Thomas A.,Morey Leslie C.,Aguglia Eugenio,Batista Rafael,Campanella Giuseppe,Conti Luciano,Dreyfus Jean-Francois,Fjetland Olaf K.,Grossi Dario,Modaferri Antonino,Marin-Perez Gustavo A.,Postiglione Alfredo,Santini Valerio,Torres-Ruiz Antonio,Vergara Luis E.

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference22 articles.

1. Diagnostic and Statistical Manual of Mental Disorders;American Psychiatric Association,1980

2. Confronto in Doppio Cieco fra un Mucopolisaccaride Solforato e Placebo nel Trattamento di Pazienti Anziani con Insufficienza Cerebrovascolare;Astengo;Clin. Ter.,1987

3. Il Sulfomucopolisaccaride nel Trattamento Dell'Insufficienza Cerebrale Dell'Anziano;Ban;Farmaci,1987

4. Global Changes with Glycosaminoglycan Polysulfate in Primary Degenerative and Multi-infarct Dementias;Ban;Curr. Therap. Res.,1987

5. Changes in Functioning with Glycosaminoglycan Polysulfate in Primary Degerative and Multi-infarct Dementias;Ban;Curr. Therap. Res.,1987

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dermatan sulfate obtained from the Phallusia nigra marine organism is responsible for antioxidant activity and neuroprotection in the neuroblastoma-2A cell lineage;International Journal of Biological Macromolecules;2020-12

2. Beta-amyloidolysis and glutathione in Alzheimer's disease;Journal of Blood Medicine;2013-04

3. Carbohydrates for improving the cognitive performance of independent-living older adults with normal cognition or mild cognitive impairment;Cochrane Database of Systematic Reviews;2011-04-13

4. Potential Applications of Glycosaminoglycan-Related Compounds in Alzheimer's Disease;Pharmacological Mechanisms in Alzheimer's Therapeutics;2007

5. C3, A Promising Ultra Low Molecular Weight Glycosaminoglycan for the Treatment of Alzheimer’s Disease;Mapping the Progress of Alzheimer’s and Parkinson’s Disease;2002